Viewing nowSingulair Chewable Tablet 4 mg (Montelukast Sodium)
Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

MFDS item code 200109139 · Approved 2001.06.26 · Insurance code 073100060
Prevention of asthma and relief of allergic rhinitis symptoms
This medication is used to prevent and treat asthma. It also helps relieve symptoms of seasonal and persistent allergic rhinitis. In other words, it is effective in managing respiratory-related allergic diseases and improving symptoms.
This medication should be taken once daily; asthma patients should take it in the evening, while allergic rhinitis patients should determine the time of administration based on their condition. Patients with both asthma and allergic rhinitis should take 1 tablet in the evening once daily. Asthma or allergic rhinitis 4 mg chewable tablet This medication should be administered 1 hour before meals or 2 hours after meals.
Children aged 2 to 5 years: Chew 4 mg of montelukast once daily. This medication should be administered 1 hour before meals or 2 hours after meals.
This medication is used to treat asthma and allergic rhinitis and should be taken consistently over the long term. During treatment, various neuropsychiatric abnormalities such as agitation, aggression, anxiety, depression, hallucinations, and suicidal thoughts may occur, so if these symptoms appear, consult a doctor immediately. This medication contains the artificial sweetener aspartame, so patients with phenylketonuria should limit its use and the daily intake of aspartame. Patients who are allergic to this medication or its components should not use it. Various adverse reactions such as dizziness, headache, dyspepsia, rash, cough, fever, etc. may occur. If symptoms persist or worsen, inform a healthcare provider. This medication is not effective during an acute asthma attack; therefore, keep emergency bronchodilators on hand at all times. Do not abruptly stop or replace inhaled corticosteroids with this medication. Do not use this medication alone for the treatment of exercise-induced bronchospasm; continue using inhaled β-agonists if necessary. Patients with known hypersensitivity to aspirin or non-steroidal anti-inflammatory drugs should not take these medications while using this medication. Rarely, eosinophilia and vasculitis symptoms may occur, so if eosinophilia, skin rash, or worsening pulmonary symptoms occur, seek medical examination immediately. No significant interactions have been reported when used with other medications, but caution should be taken and closely monitored when used with certain medications as directed by healthcare providers. Use during pregnancy should be limited to necessary cases, and caution is required when breastfeeding. Safety and efficacy have not been established in children, especially infants under 6 months of age, so it is advisable not to use in this age group. There is no specific antidote for overdose. General treatment and monitoring are required. This medication is sensitive to light, so do not open the packaging until just before taking, and take it within 15 minutes of preparation. Store in a place out of reach of children, and do not transfer to another container to maintain the quality of the medication. If asthma symptoms worsen or if emergency medication is needed more frequently, consult a healthcare provider. Do not reduce or stop the dosage of other asthma treatments without consulting a doctor.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, a severe rash accompanied by high fever, blisters, peeling skin, pain in the oral/eye mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory abnormality accompanied by cough+fever, yellowing of skin or eyes (jaundice), profound lethargy, sudden severe headache, lightning-like headache, seizures, confusion, visual abnormalities, paralysis, urinary symptoms
Dizziness, headache, malaise/fatigue, fever, abdominal pain, dyspepsia, infectious gastroenteritis, toothache, nasal congestion, cough, influenza, rash, pyuria, pharyngitis, sinusitis, nausea, diarrhea, loss of appetite, otitis, viral infections, laryngitis, runny nose, ear pain, gastroenteritis, eczema, chickenpox, pneumonia, dermatitis, conjunctivitis, drowsiness, sensory abnormalities/diminished perception, palpitations, nosebleed, diarrhea, nausea, vomiting, thrombocytopenia, itching,
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to moisture and light; therefore, it should be stored at room temperature between 1 to 30 degrees Celsius. Additionally, it is important to keep it in a tightly closed container to prevent exposure to air.
Pink chewable tablet with a biconvex oval shape
28 tablets (7 tablets/PTP x 4)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMontelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.